ArticleWorld journal of surgical oncology2021
Surgical treatment and long-term outcomes of low-grade myofibroblastic sarcoma: a single-center case series of 15 patients.
Article in World journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- Oral and Maxillofacial Low-Grade Myofibroblastic Sarcoma: A Systematic Review.Head and neck pathology · 2025Pooled it
- Synchronous low-grade myofibroblastic sarcoma and small cell lung cancer in a patient with situs inversus totalis: a case report and literature review.Frontiers in oncology · 2026Article
- Low-Grade Myofibroblastic Sarcoma of the tongue: A case report and literature review.Journal of clinical and experimental dentistry · 2025Article
- Early diagnosis and treatment of low-grade myofibroblastic sarcoma in the left distal femur: a case report and literature review.BMC musculoskeletal disorders · 2025Review
- Enhanced magnetic resonance imaging features and management principles of low-grade myofibroblastic sarcoma of the breast: a case report.Gland surgery · 2025Article
- Significant increase in calcification and ossification observed after the second relapse of low-grade myofibroblast sarcoma treated with radiotherapy followed by anlotinib and toripalimab: a case report.Frontiers in immunology · 2025Article
- Case Report: First case of low-grade myofibroblastic sarcoma of the vulva during pregnancy.Frontiers in oncology · 2025Article
- Low-Grade Myofibroblastic Sarcoma of the Acetabulum - A Rare Case with Review of Literature.Journal of orthopaedic case reports · 2025Article
- Deep Convolutional Neural Network for Accurate Classification of Myofibroblastic Lesions on Patch-Based Images.Head and neck pathology · 2024Article
- Indolent growth of low‑grade myofibroblastic sarcoma of the knee with the resemblance of a benign lesion: A case report.Oncology letters · 2024Article
- Myofibroblastic sarcoma in breast: a case report and literature review.Frontiers in oncology · 2024Article
- A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities.Journal of clinical medicine · 2023Review
- Low-Grade Myofibroblastic Sarcoma on Back with Repeated Localized Recurrence and Regional Metastasis.Annals of dermatology · 2023Article
- Article
- Low-grade myofibroblastic sarcoma of the mandible: A rare tumour of childhood.Journal of oral and maxillofacial pathology : JOMFP · 2023Article
- A rare low-grade myofibroblastic sarcoma in lower jaw with the resemblance to benign lesions.BMC oral health · 2022Article
- Effective Treatment of Low-Grade Myofibroblastic Sarcoma with Apatinib: A Case Report and Literature Review.Pharmacogenomics and personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow-grade myofibroblastic sarcoma (LGMS) is a poorly studied, rare, soft tissue sarcoma. LGMS is characterized by a low malignancy potential, tendency for local recurrence, and low likelihood of distant metastases. However, no studies have reported on the surgical treatment method and its long-term outcomes.
methodsWe included all patients treated for LGMS at our institution between March 2010 and March 2021. Medical charts were retrospectively reviewed to collect demographic information, as well as information about the clinical course, tumor characteristics, and outcomes. Statistical analysis was performed to identify the factors associated with the recurrence rate.
resultsFifteen patients who underwent surgical treatment were enrolled in this study. There were seven cases in the upper extremities, four in the trunk area, three in the lower extremities, and one in the head and neck area. There were no metastatic cases and two cases of local recurrence.
conclusionsThe incidence of LGMS in the extremities or trunk may be higher than expected based on the current literature. Univariate analysis showed that local tissue invasion and surgical method could be associated with local recurrence. Although further large studies are needed to establish risk factors of local recurrence or extent of resection margins, based on our study, wide local excision under the proper diagnosis is the most important treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.